「filing」の検索結果

共享 Ascend NPU 上的**性能验收标准**：判定"某优化到底有没有效、有多少效"，并规定 **只有验收态结果才能写入总览表**。分双态：**探索态**（平时特性分析：不展开、 允许少步/单次，产物必须标 `[探索]`、不得进总览表）vs **验收态**（入库：同窗 ≥N 复现、按 window-ab-protocol 口径出数）。当用户问"这个优化有多少收益 / 是否有效 / 要不要采纳 / 为什么变慢了""A-B 一下""同窗对比""测 3 次取平均""把数据对齐到同一窗口" "数字对不对""是不是我眼花了"，或需要在多卡共享机器上给出性能结论、刷新优化总览报表、 复核别人给的加速比时使用；即使用户只说"帮我确认下这个改动值不值"也应触发。 核心口径：同窗 A/B 是唯一权威（跨窗口绝对值不可比）、A/B/A 漂移校正、窗口内自带基线、 三次证明（HTTP 200 + 字节数 + 日志行）、产物 md5 与关键张量 dump 双证据、噪声地板内 不下结论、profiling 三张表统一到同一窗口；并覆盖 md5 门禁的盲区（忠实度对照）、 共享机器纪律与门控回退纪律。

日本語の概要は準備中です。原文の説明を表示しています。

DiT 计算模块（L3）：把**已定位的 DiT 计算瓶颈**落成特性级选档与实施—— 量化档（W8A16 / W4A16 / W8A8 系列 / W4A4 / MXFP8 / FA 量化）、稀疏（rf_v2 / ada_bsa）、 缓存（DiTCache / AttentionCache / 时间步优化）、编译启用（MindieSDBackend / Pattern 融合 / ACLGraph） 的**开不开、开哪一档、怎么开、怎么复验**；依据是 `docs/zh/features/*`（特性真源）+ framework-integration/references/framework-support-matrix.md（支持状态）。 即使用户只说"这个模型怎么加速""量化/稀疏/Cache 怎么选怎么开""要不要开量化、开哪一档""这个档位开了有没有效果" 而未提 profiling，也应触发。 **入口条件**：瓶颈点已明确（用户带一句实测锚点，或编排层交付标签）时由域入口 `performance-optimization` 按标签分发到本技能；**瓶颈未明（"怎么加速 / 跑通 / 采 profile"）先走 `model-auto-optimization` 定位**，不在本技能内做占比分析。 near-miss：多卡并行形态 / 通信掩盖 / TP·offload 选型 → `dit-parallel-opt`；VAE 解码段与 host 固定开销 → 各自模块（VAE / host）；单算子实现级实测选型（mindie_bench）→ `benchmark-dev`； 需要新增 pattern / 算子才能落地本档 → `pattern-dev` / `operator-dev`；框架侧开关与使能验证 → `framework-integration`；量化器位级契约与精度对齐（编码公式 / 舍入 / scale 粒度）→ `quantization-dev`；精度验收判据 → `accuracy-gate`；数字入库口径 → `perf-gate`。

日本語の概要は準備中です。原文の説明を表示しています。

Drafts a Petition for Writ of Certiorari to the U.S. Supreme Court under Rules 10, 13, 14, and 33. Enforces Rule 10 criteria (circuit splits, precedent conflicts, important federal questions), jurisdictional verification under 28 U.S.C. §§ 1254/1257, timeliness, document structure, and booklet formatting. Use when seeking discretionary Supreme Court review, filing a cert petition, or drafting a writ of certiorari.

日本語の概要は準備中です。原文の説明を表示しています。

Prepares jurisdiction-specific charitable solicitation registration packages for U.S. nonprofits. Covers multi-state nexus analysis, exemption eligibility, URS filing strategy, financial disclosures, and professional fundraiser documentation. Use when a nonprofit plans fundraising campaigns, online donation drives, direct mail, telephone solicitation, or any cross-state charitable solicitation.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts a FRAP 26.1-compliant Certificate of Interested Persons identifying all parties, entities, and affiliates with financial or legal interests in a federal appeal. Adapts to circuit-specific local rules. Use when filing appeals, corporate disclosure statements, or conflict-of-interest certificates in U.S. Courts of Appeals.

日本語の概要は準備中です。原文の説明を表示しています。

Generates a structured attorney work product memorandum from an initial client consultation for commercial litigation. Extracts verifiable facts from uploaded documents, builds a chronological narrative, identifies parties and contracts, flags preliminary legal claims and defenses, and produces a prioritized action plan. Triggers at matter intake when a business client needs a foundational case evaluation document for a pre-filing commercial dispute.

日本語の概要は準備中です。原文の説明を表示しています。

Produces internal case viability and conflict check memos for personal injury litigation intake. Screens conflicts, assesses liability and damages, checks statute of limitations, and outputs an accept/decline recommendation. Use when evaluating new PI intake, running conflict checks, assessing case merit pre-filing, or preparing acceptance memos.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts a formal Bylaw Amendment Resolution for U.S. corporations, LLCs, or non-profits. Invoke when a board, shareholders, or members approve bylaw changes and need an auditable WHEREAS/RESOLVED record with amendment text, vote tallies, effective date, and secretary certification for minute books, bank submissions, or state filings.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts a filing-ready U.S. complaint for breach of a purchase agreement. Trigger when the user requests a breach-of-contract complaint, forum-selection analysis, or remedy package for a real-estate or asset purchase dispute.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts an itemized Bill of Costs on Appeal under FRAP 39 or state equivalent for the prevailing party to recover allowable appellate expenses. Triggers on appellate cost bill drafting, post-judgment cost recovery filings, or prevailing party cost submissions.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts filing-ready proofs of claim for U.S. bankruptcy proceedings using Official Form B 410 under FRBP 3001. Handles secured, unsecured priority, and general unsecured claims with proper valuation, documentation, and bar date compliance. Use when a creditor needs to file or amend a proof of claim in a bankruptcy case.

日本語の概要は準備中です。原文の説明を表示しています。

Calculates pre-petition interest for bankruptcy proofs of claim and produces a filing-ready worksheet. Covers rate source hierarchy, day-count conventions, simple interest formulas, post-petition rules under 11 U.S.C. § 506(b), and fee inclusion standards. Use when preparing interest components of a proof of claim, calculating creditor claim amounts, or verifying interest calculations.

日本語の概要は準備中です。原文の説明を表示しています。

Summarizes biotech patent families and disputes into litigation-ready intelligence briefs. Trigger when the user provides patent applications, issued patents, PTAB filings, prosecution histories, licensing materials, or litigation documents in biotechnology domains and requests a summary, risk assessment, or FTO analysis.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts filing-ready Articles of Incorporation for U.S. non-profit corporations satisfying state corporate law and the IRS organizational test under IRC § 501(c)(3). Enforces mandatory exempt-purpose language, private inurement prohibition, dissolution clause, and political activity limitations. Use when forming a new non-profit, charitable corporation, or tax-exempt entity seeking 501(c)(3) recognition.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts jurisdiction-compliant U.S. Articles of Incorporation for corporate entity formation. Analyzes formation documents, term sheets, and cap tables to produce a filing-ready charter with name, purpose, capital structure, registered agent, and governance provisions. Use when forming a new corporation, drafting a charter document, or structuring equity for venture-backed or closely held companies.

日本語の概要は準備中です。原文の説明を表示しています。

Summarizes raw background check data into structured executive reports with risk categorization (GREEN/YELLOW/RED). Use when processing criminal records, court filings, employment/education verification, sanctions screening, or adverse media for pre-employment screening, executive due diligence, or investment-grade investigations.

日本語の概要は準備中です。原文の説明を表示しています。

Verifies legal citations and retrieves source material using the case.dev Legal Research API and CLI. Use when validating a citation, confirming a case exists, pulling source text, finding related authorities, extracting citations from a brief or opinion, or building a filing-ready authority check without branded citator terminology.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts an asbestos abatement plan compliant with OSHA 29 CFR 1926.1101 and EPA NESHAP 40 CFR 61 Subpart M. Extracts facility details from uploaded surveys and contractor documents to produce a regulatory filing and operational guide. Use when preparing pre-abatement regulatory submissions, contractor work plans, or facility owner compliance documentation for asbestos removal projects.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts the "Interest of Amicus Curiae" section of an amicus brief. Establishes institutional credibility, tethers the amicus's interest to the specific legal question, articulates non-party impacts, and embeds disclosure guardrails under FRAP 29 and Supreme Court Rule 37. Trigger when drafting amicus briefs, friend-of-the-court filings, interest statements, amicus disclosures, or when the user asks why an organization belongs in a case.

日本語の概要は準備中です。原文の説明を表示しています。

Generates appellate-brief TOC, TOA, and Certificate of Compliance with defensible word-count methodology. Triggers on TOC/TOA rebuilds, certificate of compliance drafting, FRAP 32(g) compliance, word-count certification, or final brief formatting before filing.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts a Notice of Alibi Defense under Fed. R. Crim. P. 12.1 or state equivalents. Triggers on alibi notice drafting, alibi defense filing, Rule 12.1 disclosure, or pre-trial criminal defense notice tasks.

日本語の概要は準備中です。原文の説明を表示しています。

Comprehensive legal applications skill covering civil/criminal/administrative litigation workflows, trial defense strategies, legal document drafting (complaints, answers, appeals, retrial petitions, enforcement applications, representation opinions, defense statements, legal opinions, etc.), arbitration (commercial & labor), mediation, enforcement procedures, evidence rules, and litigation risk assessment. Trigger when users ask about: lawsuit/litigation/trial, legal documents, court defense, evidence/cross-examination, arbitration, enforcement, legal strategy, filing a case, appeal, retrial, representation, pleading, or any legal procedural guidance.

日本語の概要は準備中です。原文の説明を表示しています。

Produces litigation-grade case summaries for animal law disputes including cruelty/neglect prosecutions, ownership/custody, dangerous animal designations, veterinary malpractice, and service/assistance animal accommodations. Builds exhibit-cited factual timelines, maps evidence to statutory elements, evaluates expert evidence, and assesses remedies with jurisdiction-specific legal research. Use when summarizing animal law cases, analyzing animal cruelty charges, pet custody disputes, dangerous dog hearings, veterinary malpractice claims, or assistance animal accommodation matters. Also trigger for animal forfeiture, bite liability, wildlife possession, or animal-related court filings.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts FDA 510(k) Premarket Notification submissions demonstrating substantial equivalence under 21 CFR Part 807. Supports Traditional, Special, and Abbreviated pathways. Use when preparing Class II medical device regulatory filings, substantial equivalence analyses, or FDA premarket submissions.

日本語の概要は準備中です。原文の説明を表示しています。